 WALTHAM, Mass., Nov. 17, 2020 GLOBE NEWSWIRE -- Morphic Therapeutic NASDAQ: MORF, a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment of serious chronic diseases, today announced that members of the Morphic management are scheduled to participate in the Jefferies Virtual London Healthcare Conference with a Company presentation at 2:55 PM ET on Wednesday, November 18, 2020. 